VIRIDIAN THERAPEUTICS INC's ticker is VRDN and the CUSIP is 92790C104. A total of 139 filers reported holding VIRIDIAN THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.29 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $727,699 | -32.0% | 47,438 | +5.4% | 0.22% | -33.2% |
| Q2 2023 | $1,070,550 | +15.7% | 45,000 | +23.7% | 0.33% | -13.4% |
| Q1 2023 | $925,533 | +956.2% | 36,381 | +1112.7% | 0.38% | +1428.0% |
| Q4 2022 | $87,630 | -96.2% | 3,000 | -97.6% | 0.02% | -97.4% |
| Q1 2022 | $2,332,000 | -4.7% | 126,136 | +1.9% | 0.96% | -2.7% |
| Q4 2021 | $2,448,000 | +40.3% | 123,806 | +16.7% | 0.99% | +0.5% |
| Q3 2021 | $1,745,000 | +236.2% | 106,078 | +273.5% | 0.99% | +327.3% |
| Q2 2021 | $519,000 | +12.6% | 28,399 | +2.9% | 0.23% | -8.0% |
| Q1 2021 | $461,000 | – | 27,586 | – | 0.25% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| VR Adviser, LLC | 3,082,622 | $47,287,421 | 4.98% |
| COMMODORE CAPITAL LP | 2,200,000 | $33,748,000 | 3.94% |
| Paradigm Biocapital Advisors LP | 3,681,747 | $56,477,999 | 3.83% |
| Vivo Capital, LLC | 1,678,207 | $25,743,695 | 2.82% |
| Fairmount Funds Management LLC | 1,369,623 | $21,010,017 | 2.53% |
| Octagon Capital Advisors LP | 1,067,143 | $16,369,974 | 2.52% |
| ACUTA CAPITAL PARTNERS, LLC | 224,339 | $3,441,360 | 2.31% |
| Logos Global Management LP | 1,050,000 | $16,107,000 | 2.15% |
| Kopp Family Office, LLC | 214,290 | $3,287 | 2.08% |
| 5AM Venture Management, LLC | 410,000 | $6,289,400 | 1.81% |